newsfilter
← Latest News
ACCESS Newswire·

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

This Phase 2 clinical study will evaluate paridiprubart in hospitalized patients with acute respiratory distress syndrome due to a variety of causes.This BARDA-funded project is expected to complement